Elekta (OTCMKTS:EKTAY) Sees Unusually-High Trading Volume – What’s Next?

Elekta AB (OTCMKTS:EKTAY) shares saw unusually-strong trading volume on Friday . Approximately 6,334 shares were traded during mid-day trading, an increase of 134% from the previous session’s volume of 2,706 shares.The stock last traded at $6.33 and had previously closed at $6.74.

Elekta Price Performance

The company has a quick ratio of 0.79, a current ratio of 1.04 and a debt-to-equity ratio of 0.66. The stock has a market capitalization of $2.36 billion, a PE ratio of 91.44 and a beta of 1.04. The company has a 50-day moving average of $6.15 and a 200 day moving average of $5.38.

Elekta (OTCMKTS:EKTAY) last posted its earnings results on Wednesday, November 26th. The company reported $0.07 earnings per share (EPS) for the quarter. The firm had revenue of $427.85 million during the quarter, compared to analysts’ expectations of $436.91 million. Elekta had a net margin of 1.62% and a return on equity of 12.14%. Sell-side analysts predict that Elekta AB will post 0.36 EPS for the current year.

About Elekta

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.